These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7961009)

  • 41. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break.
    Xu L; Pan J; Wu J; Pan C; Zhang Y; Lin S; Yang L; Chen C; Zhang C; Zheng W; Lin S; Ni X; Kong FM
    Radiother Oncol; 2010 Jul; 96(1):94-9. PubMed ID: 20435361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Radiation therapy of nasopharyngeal carcinoma: treatment results and prognostic factors].
    Chatani M; Matayoshi Y; Masaki N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):945-52. PubMed ID: 8371943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical characteristics and prognosis of aged nasopharyngeal carcinoma patients: a report of 313 cases].
    Zeng Q; Guo X; Li NW; Xiang YQ; Cao SM; Hong MH
    Ai Zheng; 2008 Mar; 27(3):289-94. PubMed ID: 18334119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term efficacy of prophylactic upper neck irradiation for stage N0 nasopharyngeal carcinoma].
    Chen CZ; Li DR; Chen ZJ; Li DS; Guo LJ; Guo H
    Ai Zheng; 2008 Mar; 27(3):295-8. PubMed ID: 18334120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.
    Chua DT; Sham JS; Kwong DL; Au GK
    Cancer; 2003 Jul; 98(1):74-80. PubMed ID: 12833458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Quality of life of 192 disease-freely survival nasopharyngeal carcinoma patients after radiotherapy].
    Wu Y; Hu WH; Xia YF; Ma J; Liu MZ; Cui NJ
    Ai Zheng; 2005 Nov; 24(11):1376-83. PubMed ID: 16552967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system.
    Lee AW; Foo W; Law SC; Poon YF; O SK; Tung SY; Sze WM; Chappell R; Lau WH; Ho JH
    Int J Cancer; 1999 Apr; 84(2):179-87. PubMed ID: 10096252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma.
    Hong MH; Mai HQ; Min HQ; Ma J; Zhang EP; Cui NJ
    Cancer; 2000 Jul; 89(2):242-7. PubMed ID: 10918151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer of the nasopharynx in childhood.
    Huang TB
    Cancer; 1990 Sep; 66(5):968-71. PubMed ID: 2386925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma.
    Teo PM; Tsao SY; Ho JH; Yu P
    Radiother Oncol; 1991 May; 21(1):11-23. PubMed ID: 1852915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of staging system for nasopharyngeal carcinoma: comparison of fourth and fifth editions of UICC TNM classification.
    Tatsumi-Tamori A; Yoshizaki T; Miwa T; Furukawa M
    Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1125-9. PubMed ID: 11130824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients.
    Sham JS; Choy D
    Br J Radiol; 1990 Jan; 63(745):51-8. PubMed ID: 2306588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computed tomography in nasopharyngeal carcinoma: Part II: Impact on survival.
    Cellai E; Olmi P; Chiavacci A; Giannardi G; Fargnoli R; Villari N; Fallai C
    Int J Radiat Oncol Biol Phys; 1990 Nov; 19(5):1177-82. PubMed ID: 2254109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of the Chinese staging system for nasopharyngeal carcinoma.
    Zong J; Huang Q; Guo Q; Pan J
    Chin Clin Oncol; 2016 Apr; 5(2):19. PubMed ID: 27121879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nasopharyngeal carcinoma (NPC): comparison of clinical staging-systems].
    Bertram G; Sesterhenn K; Mödder U
    HNO; 1982 Jul; 30(7):235-42. PubMed ID: 7118591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional Stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy.
    Cooper JS; del Rowe J; Newall J
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1737-45. PubMed ID: 6417075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma.
    Neel HB; Taylor WF; Pearson GR
    Ann Otol Rhinol Laryngol; 1985; 94(6 Pt 1):529-37. PubMed ID: 4073727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study.
    Liu Q; Chen JO; Huang QH; Li YH
    Chin J Cancer; 2013 Jun; 32(6):325-33. PubMed ID: 23237219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.